$SCMP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sucampo Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sucampo Pharmaceuticals, Inc.. Get notifications about new insider transactions in Sucampo Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 25 2014 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.77 | 28,700 | 194,351 | 22,985,702 | 23 M to 23 M (-0.12 %) |
Apr 25 2014 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.73 | 38,700 | 260,478 | 23,014,402 | 23.1 M to 23 M (-0.17 %) |
Apr 22 2014 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.82 | 75,400 | 514,590 | 23,053,102 | 23.1 M to 23.1 M (-0.33 %) |
Apr 22 2014 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.71 | 23,800 | 159,800 | 23,128,502 | 23.2 M to 23.1 M (-0.10 %) |
Apr 22 2014 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.74 | 28,500 | 192,079 | 23,152,302 | 23.2 M to 23.2 M (-0.12 %) |
Apr 22 2014 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | 10% Owner | Sell | S | 6.82 | 75,400 | 514,590 | 23,053,102 | 23.1 M to 23.1 M (-0.33 %) |
Apr 22 2014 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | 10% Owner | Sell | S | 6.71 | 23,800 | 159,800 | 23,128,502 | 23.2 M to 23.1 M (-0.10 %) |
Apr 22 2014 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | 10% Owner | Sell | S | 6.74 | 28,500 | 192,079 | 23,152,302 | 23.2 M to 23.2 M (-0.12 %) |
Apr 22 2014 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.82 | 75,400 | 514,590 | 23,053,102 | 23.1 M to 23.1 M (-0.33 %) |
Apr 22 2014 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.71 | 23,800 | 159,800 | 23,128,502 | 23.2 M to 23.1 M (-0.10 %) |
Apr 22 2014 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.74 | 28,500 | 192,079 | 23,152,302 | 23.2 M to 23.2 M (-0.12 %) |
Mar 21 2014 | SCMP | Sucampo Pharmaceut ... | Dolecek Gayle R | Director | Option Exercise | M | 4.41 | 1,200 | 5,292 | 313,367 | |
Mar 21 2014 | SCMP | Sucampo Pharmaceut ... | Dolecek Gayle R | Director | Sell | S | 8.03 | 1,200 | 9,636 | 0 | 1.2 K to 0 (-100.00 %) |
Mar 21 2014 | SCMP | Sucampo Pharmaceut ... | Dolecek Gayle R | Director | Buy | M | 4.41 | 1,200 | 5,292 | 1,200 | 0 to 1.2 K |
Mar 05 2014 | SCMP | Sucampo Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Option Exercise | A | 8.49 | 600,000 | 5,094,000 | 600,000 | |
Feb 28 2014 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief Financial Off ... | Option Exercise | M | 4.07 | 2,500 | 10,175 | 102,960 | |
Feb 28 2014 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief Financial Off ... | Sell | S | 9.06 | 110 | 997 | 0 | 110 to 0 (-100.00 %) |
Feb 28 2014 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief Financial Off ... | Sell | S | 9.00 | 2,390 | 21,510 | 110 | 2.5 K to 110 (-95.60 %) |
Feb 28 2014 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief Financial Off ... | Buy | M | 4.07 | 2,500 | 10,175 | 2,500 | 0 to 2.5 K |
Feb 21 2014 | SCMP | Sucampo Pharmaceut ... | Dolecek Gayle R | Director | Option Exercise | M | 4.41 | 9,067 | 39,985 | 314,567 | |
Feb 21 2014 | SCMP | Sucampo Pharmaceut ... | Dolecek Gayle R | Director | Sell | S | 8.04 | 9,067 | 72,899 | 0 | 9.1 K to 0 (-100.00 %) |
Feb 21 2014 | SCMP | Sucampo Pharmaceut ... | Dolecek Gayle R | Director | Buy | M | 4.41 | 9,067 | 39,985 | 9,067 | 0 to 9.1 K |
Feb 19 2014 | SCMP | Sucampo Pharmaceut ... | Celeste Anthony C. | Director | Option Exercise | M | 4.41 | 4,800 | 21,168 | 56,200 | |
Feb 19 2014 | SCMP | Sucampo Pharmaceut ... | Celeste Anthony C. | Director | Option Exercise | M | 4.41 | 9,000 | 39,690 | 61,000 | |
Feb 19 2014 | SCMP | Sucampo Pharmaceut ... | Celeste Anthony C. | Director | Option Exercise | M | 3.56 | 20,000 | 71,200 | 70,000 | |
Feb 19 2014 | SCMP | Sucampo Pharmaceut ... | Celeste Anthony C. | Director | Option Exercise | M | 5.10 | 30,000 | 153,000 | 90,000 | |
Feb 19 2014 | SCMP | Sucampo Pharmaceut ... | Celeste Anthony C. | Director | Buy | M | 4.41 | 13,800 | 60,858 | 68,800 | 55 K to 68.8 K (+25.09 %) |
Feb 19 2014 | SCMP | Sucampo Pharmaceut ... | Celeste Anthony C. | Director | Buy | M | 3.56 | 20,000 | 71,200 | 55,000 | 35 K to 55 K (+57.14 %) |
Feb 19 2014 | SCMP | Sucampo Pharmaceut ... | Celeste Anthony C. | Director | Buy | M | 5.10 | 30,000 | 153,000 | 35,000 | 5 K to 35 K (+600.00 %) |
Jan 23 2014 | SCMP | Sucampo Pharmaceut ... | Dolecek Gayle R | Director | Option Exercise | M | 4.41 | 9,066 | 39,981 | 323,634 | |
Jan 23 2014 | SCMP | Sucampo Pharmaceut ... | Dolecek Gayle R | Director | Sell | S | 9.21 | 9,066 | 83,498 | 0 | 9.1 K to 0 (-100.00 %) |
Jan 23 2014 | SCMP | Sucampo Pharmaceut ... | Dolecek Gayle R | Director | Buy | M | 4.41 | 9,066 | 39,981 | 9,066 | 0 to 9.1 K |
Jan 22 2014 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 10.36 | 360,000 | 3,728,412 | 24,180,802 | 24.5 M to 24.2 M (-1.47 %) |
Jan 22 2014 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 10.36 | 360,000 | 3,728,412 | 24,180,802 | 24.5 M to 24.2 M (-1.47 %) |
Jan 22 2014 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 10.36 | 360,000 | 3,728,412 | 24,180,802 | 24.5 M to 24.2 M (-1.47 %) |
Jan 09 2014 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief Financial Off ... | Option Exercise | M | 4.07 | 100 | 407 | 105,460 | |
Jan 09 2014 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief Financial Off ... | Option Exercise | M | 4.41 | 2,400 | 10,584 | 105,560 | |
Jan 09 2014 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief Financial Off ... | Sell | S | 9.00 | 2,500 | 22,500 | 0 | 2.5 K to 0 (-100.00 %) |
Jan 09 2014 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief Financial Off ... | Buy | M | 4.07 | 100 | 407 | 2,500 | 2.4 K to 2.5 K (+4.17 %) |
Jan 09 2014 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief Financial Off ... | Buy | M | 4.41 | 2,400 | 10,584 | 2,400 | 0 to 2.4 K |
Jan 06 2014 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief Financial Off ... | Grant | A | 8.93 | 196 | 1,750 | 2,134 | 1.9 K to 2.1 K (+10.11 %) |
Dec 18 2013 | SCMP | Sucampo Pharmaceut ... | Dolecek Gayle R | Director | Option Exercise | X | 4.41 | 45,000 | 198,450 | 332,700 | |
Dec 18 2013 | SCMP | Sucampo Pharmaceut ... | Dolecek Gayle R | Director | Option Exercise | X | 4.41 | 9,400 | 41,454 | 377,700 | |
Dec 18 2013 | SCMP | Sucampo Pharmaceut ... | Dolecek Gayle R | Director | Sell | X | 8.00 | 54,400 | 435,200 | 332,700 | 387.1 K to 332.7 K (-14.05 %) |
Nov 26 2013 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief financial off ... | Option Exercise | X | 4.07 | 49 | 199 | 109,898 | |
Nov 26 2013 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief financial off ... | Option Exercise | X | 4.07 | 12,940 | 52,666 | 109,947 | |
Nov 26 2013 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief financial off ... | Option Exercise | X | 4.07 | 3,511 | 14,290 | 122,887 | |
Nov 26 2013 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief financial off ... | Sell | X | 7.64 | 12,989 | 99,236 | 109,898 | 122.9 K to 109.9 K (-10.57 %) |
Nov 26 2013 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief financial off ... | Sell | X | 7.46 | 3,511 | 26,192 | 122,887 | 126.4 K to 122.9 K (-2.78 %) |
Nov 26 2013 | SCMP | Sucampo Pharmaceut ... | Miele Stanley G | SVP, Sales & Market ... | Option Exercise | X | 4.41 | 50,000 | 220,500 | 173,400 | |
Nov 26 2013 | SCMP | Sucampo Pharmaceut ... | Miele Stanley G | SVP, Sales & Market ... | Sell | X | 7.50 | 50,000 | 375,000 | 173,400 | 223.4 K to 173.4 K (-22.38 %) |
Oct 18 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 6.35 | 360,000 | 2,287,116 | 24,540,802 | 24.9 M to 24.5 M (-1.45 %) |
Oct 18 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.35 | 360,000 | 2,287,116 | 24,540,802 | 24.9 M to 24.5 M (-1.45 %) |
Oct 01 2013 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief financial off ... | Grant | A | 5.93 | 253 | 1,500 | 1,938 | 1.7 K to 1.9 K (+15.01 %) |
Oct 18 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.35 | 360,000 | 2,287,116 | 24,540,802 | 24.9 M to 24.5 M (-1.45 %) |
Sep 18 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 5.69 | 11,200 | 63,754 | 24,900,802 | 24.9 M to 24.9 M (-0.04 %) |
Sep 18 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 5.73 | 12,600 | 72,207 | 24,912,002 | 24.9 M to 24.9 M (-0.05 %) |
Sep 18 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 5.64 | 14,662 | 82,700 | 24,924,602 | 24.9 M to 24.9 M (-0.06 %) |
Sep 18 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 5.69 | 11,200 | 63,754 | 24,900,802 | 24.9 M to 24.9 M (-0.04 %) |
Sep 18 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 5.73 | 12,600 | 72,207 | 24,912,002 | 24.9 M to 24.9 M (-0.05 %) |
Sep 18 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 5.64 | 14,662 | 82,700 | 24,924,602 | 24.9 M to 24.9 M (-0.06 %) |
Sep 18 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 5.69 | 11,200 | 63,754 | 24,900,802 | 24.9 M to 24.9 M (-0.04 %) |
Sep 18 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 5.73 | 12,600 | 72,207 | 24,912,002 | 24.9 M to 24.9 M (-0.05 %) |
Sep 18 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 5.64 | 14,662 | 82,700 | 24,924,602 | 24.9 M to 24.9 M (-0.06 %) |
Sep 05 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 5.59 | 38,462 | 214,887 | 24,939,264 | 25 M to 24.9 M (-0.15 %) |
Sep 05 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 5.59 | 38,462 | 214,887 | 24,939,264 | 25 M to 24.9 M (-0.15 %) |
Sep 05 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 5.59 | 38,462 | 214,887 | 24,939,264 | 25 M to 24.9 M (-0.15 %) |
Aug 21 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.04 | 38,462 | 232,257 | 24,977,726 | 25 M to 25 M (-0.15 %) |
Aug 21 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.04 | 38,462 | 232,257 | 24,977,726 | 25 M to 25 M (-0.15 %) |
Aug 21 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 6.04 | 38,462 | 232,257 | 24,977,726 | 25 M to 25 M (-0.15 %) |
Aug 07 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 6.21 | 24,100 | 149,671 | 25,016,188 | 25 M to 25 M (-0.10 %) |
Aug 07 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 6.20 | 14,362 | 88,991 | 25,040,288 | 25.1 M to 25 M (-0.06 %) |
Aug 07 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.21 | 24,100 | 149,671 | 25,016,188 | 25 M to 25 M (-0.10 %) |
Aug 07 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.20 | 14,362 | 88,991 | 25,040,288 | 25.1 M to 25 M (-0.06 %) |
Aug 07 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.21 | 24,100 | 149,671 | 25,016,188 | 25 M to 25 M (-0.10 %) |
Aug 07 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.20 | 14,362 | 88,991 | 25,040,288 | 25.1 M to 25 M (-0.06 %) |
Jul 24 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.46 | 20,700 | 133,805 | 25,054,650 | 25.1 M to 25.1 M (-0.08 %) |
Jul 24 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.60 | 12,300 | 81,158 | 25,075,350 | 25.1 M to 25.1 M (-0.05 %) |
Jul 24 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.57 | 5,462 | 35,873 | 25,087,650 | 25.1 M to 25.1 M (-0.02 %) |
Jul 24 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.46 | 20,700 | 133,805 | 25,054,650 | 25.1 M to 25.1 M (-0.08 %) |
Jul 24 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.60 | 12,300 | 81,158 | 25,075,350 | 25.1 M to 25.1 M (-0.05 %) |
Jul 24 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.57 | 5,462 | 35,873 | 25,087,650 | 25.1 M to 25.1 M (-0.02 %) |
Jul 24 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 6.46 | 20,700 | 133,805 | 25,054,650 | 25.1 M to 25.1 M (-0.08 %) |
Jul 24 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 6.60 | 12,300 | 81,158 | 25,075,350 | 25.1 M to 25.1 M (-0.05 %) |
Jul 24 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 6.57 | 5,462 | 35,873 | 25,087,650 | 25.1 M to 25.1 M (-0.02 %) |
Jul 10 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 6.49 | 10,300 | 66,810 | 25,093,112 | 25.1 M to 25.1 M (-0.04 %) |
Jul 10 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 6.48 | 28,162 | 182,450 | 25,103,412 | 25.1 M to 25.1 M (-0.11 %) |
Jul 10 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.49 | 10,300 | 66,810 | 25,093,112 | 25.1 M to 25.1 M (-0.04 %) |
Jul 10 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.48 | 28,162 | 182,450 | 25,103,412 | 25.1 M to 25.1 M (-0.11 %) |
Jul 10 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.49 | 10,300 | 66,810 | 25,093,112 | 25.1 M to 25.1 M (-0.04 %) |
Jul 10 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.48 | 28,162 | 182,450 | 25,103,412 | 25.1 M to 25.1 M (-0.11 %) |
Jun 26 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 6.61 | 38,462 | 254,234 | 25,131,574 | 25.2 M to 25.1 M (-0.15 %) |
Jun 26 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.61 | 38,462 | 254,234 | 25,131,574 | 25.2 M to 25.1 M (-0.15 %) |
Jun 26 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.61 | 38,462 | 254,234 | 25,131,574 | 25.2 M to 25.1 M (-0.15 %) |
Jun 12 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 7.29 | 38,462 | 280,384 | 25,170,036 | 25.2 M to 25.2 M (-0.15 %) |
Jun 12 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 7.29 | 38,462 | 280,384 | 25,170,036 | 25.2 M to 25.2 M (-0.15 %) |
Jun 12 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 7.29 | 38,462 | 280,384 | 25,170,036 | 25.2 M to 25.2 M (-0.15 %) |
Jun 05 2013 | SCMP | Sucampo Pharmaceut ... | MAUDLIN TIMOTHY I | Director | Option Exercise | P | 5.18 | 32,870 | 170,267 | 32,870 | |
Jun 05 2013 | SCMP | Sucampo Pharmaceut ... | MAUDLIN TIMOTHY I | Director | Buy | P | 9.82 | 32,870 | 322,783 | 32,870 | 0 to 32.9 K |
May 30 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 8.79 | 38,462 | 338,193 | 25,208,498 | 25.2 M to 25.2 M (-0.15 %) |
May 30 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 8.79 | 38,462 | 338,193 | 25,208,498 | 25.2 M to 25.2 M (-0.15 %) |
May 30 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 8.79 | 38,462 | 338,193 | 25,208,498 | 25.2 M to 25.2 M (-0.15 %) |
May 30 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 8.79 | 38,462 | 338,193 | 25,208,498 | 25.2 M to 25.2 M (-0.15 %) |
May 30 2013 | SCMP | Sucampo Pharmaceut ... | Tolliver Kei S | Director | Option Exercise | A | 8.62 | 30,000 | 258,600 | 30,000 | |
May 30 2013 | SCMP | Sucampo Pharmaceut ... | Tolliver Kei S | Director | Option Exercise | A | 8.62 | 30,000 | 258,600 | 30,000 | |
May 30 2013 | SCMP | Sucampo Pharmaceut ... | Ashton William | Director | Option Exercise | A | 8.62 | 20,000 | 172,400 | 120,000 | |
May 30 2013 | SCMP | Sucampo Pharmaceut ... | MUNDER BARBARA A | Director | Option Exercise | A | 8.62 | 20,000 | 172,400 | 50,000 | |
May 30 2013 | SCMP | Sucampo Pharmaceut ... | Getman Daniel P | Director | Option Exercise | A | 8.62 | 20,000 | 172,400 | 70,000 | |
May 30 2013 | SCMP | Sucampo Pharmaceut ... | Celeste Anthony C. | Director | Option Exercise | A | 8.62 | 20,000 | 172,400 | 120,000 | |
May 30 2013 | SCMP | Sucampo Pharmaceut ... | OCONNELL MAUREEN | Director | Option Exercise | A | 8.62 | 20,000 | 172,400 | 50,000 | |
May 29 2013 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief financial off ... | Option Exercise | X | 4.41 | 2,000 | 8,820 | 125,865 | |
May 29 2013 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief financial off ... | Option Exercise | X | 4.07 | 8,300 | 33,781 | 127,865 | |
May 29 2013 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief financial off ... | Sell | X | 9.00 | 10,300 | 92,735 | 125,865 | 136.2 K to 125.9 K (-7.56 %) |
May 21 2013 | SCMP | Sucampo Pharmaceut ... | Miele Stanley G | SVP, Sales and Mark ... | Sell | S | 9.60 | 6,400 | 61,454 | 223,200 | 229.6 K to 223.2 K (-2.79 %) |
May 22 2013 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief Financial Off ... | Sell | S | 9.55 | 2,400 | 22,914 | 136,165 | 138.6 K to 136.2 K (-1.73 %) |
May 22 2013 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief Financial Off ... | Sell | S | 9.50 | 2,240 | 21,280 | 138,565 | 140.8 K to 138.6 K (-1.59 %) |
May 17 2013 | SCMP | Sucampo Pharmaceut ... | Miele Stanley G | SVP, Sales and Mark ... | Sell | S | 9.67 | 48,600 | 470,035 | 229,600 | 278.2 K to 229.6 K (-17.47 %) |
May 15 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 9.27 | 38,462 | 356,585 | 25,246,960 | 25.3 M to 25.2 M (-0.15 %) |
May 15 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 9.27 | 38,462 | 356,585 | 25,246,960 | 25.3 M to 25.2 M (-0.15 %) |
May 15 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 9.27 | 38,462 | 356,585 | 25,246,960 | 25.3 M to 25.2 M (-0.15 %) |
May 01 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 9.28 | 38,462 | 357,062 | 25,285,422 | 25.3 M to 25.3 M (-0.15 %) |
May 01 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 9.28 | 38,462 | 357,062 | 25,285,422 | 25.3 M to 25.3 M (-0.15 %) |
May 01 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 9.28 | 38,462 | 357,062 | 25,285,422 | 25.3 M to 25.3 M (-0.15 %) |
Apr 17 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 6.81 | 2,600 | 17,702 | 25,323,884 | 25.3 M to 25.3 M (-0.01 %) |
Apr 17 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 6.87 | 35,862 | 246,300 | 25,326,484 | 25.4 M to 25.3 M (-0.14 %) |
Apr 17 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.81 | 2,600 | 17,702 | 25,323,884 | 25.3 M to 25.3 M (-0.01 %) |
Apr 17 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.87 | 35,862 | 246,300 | 25,326,484 | 25.4 M to 25.3 M (-0.14 %) |
Apr 17 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.81 | 2,600 | 17,702 | 25,323,884 | 25.3 M to 25.3 M (-0.01 %) |
Apr 17 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.87 | 35,862 | 246,300 | 25,326,484 | 25.4 M to 25.3 M (-0.14 %) |
Apr 03 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 6.25 | 38,462 | 240,476 | 25,362,346 | 25.4 M to 25.4 M (-0.15 %) |
Apr 05 2013 | SCMP | Sucampo Pharmaceut ... | Claiborne Cary J | Chief financial off ... | Grant | A | 6.21 | 242 | 1,504 | 1,405 | 1.2 K to 1.4 K (+20.81 %) |
Apr 03 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 6.25 | 38,462 | 240,476 | 25,362,346 | 25.4 M to 25.4 M (-0.15 %) |
Apr 03 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 6.25 | 38,462 | 240,476 | 25,362,346 | 25.4 M to 25.4 M (-0.15 %) |
Mar 20 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 5.28 | 38,462 | 203,218 | 25,400,808 | 25.4 M to 25.4 M (-0.15 %) |
Mar 20 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 5.28 | 38,462 | 203,218 | 25,400,808 | 25.4 M to 25.4 M (-0.15 %) |
Mar 20 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 5.28 | 38,462 | 203,218 | 25,400,808 | 25.4 M to 25.4 M (-0.15 %) |
Mar 08 2013 | SCMP | Sucampo Pharmaceut ... | OCONNELL MAUREEN | Director | Option Exercise | A | 5.19 | 30,000 | 155,700 | 30,000 | |
Mar 08 2013 | SCMP | Sucampo Pharmaceut ... | MUNDER BARBARA A | Director | Option Exercise | A | 5.19 | 30,000 | 155,700 | 30,000 | |
Mar 06 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 5.04 | 38,462 | 193,752 | 25,439,270 | 25.5 M to 25.4 M (-0.15 %) |
Mar 06 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 5.04 | 38,462 | 193,752 | 25,439,270 | 25.5 M to 25.4 M (-0.15 %) |
Mar 06 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 5.04 | 38,462 | 193,752 | 25,439,270 | 25.5 M to 25.4 M (-0.15 %) |
Feb 21 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 5.14 | 38,462 | 197,729 | 25,477,732 | 25.5 M to 25.5 M (-0.15 %) |
Feb 21 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 5.00 | 29,307 | 146,626 | 25,516,194 | 25.5 M to 25.5 M (-0.11 %) |
Feb 21 2013 | SCMP | Sucampo Pharmaceut ... | Ueno Ryuji | CEO, Chief Scientif ... | Sell | S | 5.00 | 867 | 4,339 | 25,545,501 | 25.5 M to 25.5 M (0.00 %) |
Feb 21 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 5.14 | 38,462 | 197,729 | 25,477,732 | 25.5 M to 25.5 M (-0.15 %) |
Feb 21 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 5.00 | 29,307 | 146,626 | 25,516,194 | 25.5 M to 25.5 M (-0.11 %) |
Feb 21 2013 | SCMP | Sucampo Pharmaceut ... | S&R Technology Holdings, LLC | 10% Owner | Sell | S | 5.00 | 867 | 4,339 | 25,545,501 | 25.5 M to 25.5 M (0.00 %) |
Feb 21 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 5.14 | 38,462 | 197,729 | 25,477,732 | 25.5 M to 25.5 M (-0.15 %) |
Feb 21 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 5.00 | 29,307 | 146,626 | 25,516,194 | 25.5 M to 25.5 M (-0.11 %) |
Feb 21 2013 | SCMP | Sucampo Pharmaceut ... | Kuno Sachiko | 10% Owner | Sell | S | 5.00 | 867 | 4,339 | 25,545,501 | 25.5 M to 25.5 M (0.00 %) |